Identification of a Novel Core Structure of Apo-Ido1 Inhibitors Through Virtual Screening and Preliminary Hit Optimization

= 0.29 μM). The established VS workflow effectively applied to IDO1 and can also be applied to similar targets. The novel apo-IDO1 inhibitor core structure provides a starting point for potential antitumor drug development.